10.1155/2011/796025 9 KlicekR.KolencD.SuranJ.DrmicD.BrcicL.AralicaG.et al (2013)
Effect of Empagliflozin on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial
This variability likely reflects differences in study populations, such as the presence or absence of T2DM, degree of obesity, sex distribution, and comorbid conditions, as well as differences in intervention characteristics, including the type, dose, and duration of GLP-1 RA therapy
Structure and Mechanism of Action The Ghk-Cu peptide works by binding copper ions, essential for several biochemical processes
Conclusion The combination of fish oil and glutathione presents an exciting possibility for enhancing our overall wellness
The aspartate aminotransferase-to-alanine aminotransferase ratio predicts all-cause and cardiovascular mortality in patients with type 2 diabetes